Ultralife Co. (NASDAQ:ULBI – Get Free Report) saw a large increase in short interest in the month of December. As of December 15th, there was short interest totalling 181,100 shares, an increase of 19.3% from the November 30th total of 151,800 shares. Based on an average daily trading volume, of 65,200 shares, the short-interest ratio is currently 2.8 days. Currently, 1.8% of the company’s shares are sold short.
Ultralife Stock Down 0.5 %
Shares of ULBI stock traded down $0.04 on Monday, hitting $7.25. The stock had a trading volume of 73,052 shares, compared to its average volume of 76,944. Ultralife has a one year low of $6.36 and a one year high of $13.39. The business has a 50 day moving average price of $7.95 and a 200 day moving average price of $9.36. The company has a market cap of $120.55 million, a PE ratio of 13.18 and a beta of 0.95. The company has a quick ratio of 1.62, a current ratio of 3.30 and a debt-to-equity ratio of 0.04.
Analyst Upgrades and Downgrades
A number of equities analysts have recently commented on ULBI shares. StockNews.com lowered shares of Ultralife from a “strong-buy” rating to a “buy” rating in a research report on Thursday, October 3rd. Benchmark reissued a “buy” rating and issued a $14.00 price objective on shares of Ultralife in a research note on Friday, November 15th.
Institutional Investors Weigh In On Ultralife
Large investors have recently modified their holdings of the business. Rhumbline Advisers raised its position in shares of Ultralife by 1,728.3% in the 2nd quarter. Rhumbline Advisers now owns 11,811 shares of the technology company’s stock worth $125,000 after acquiring an additional 11,165 shares in the last quarter. Barclays PLC grew its stake in Ultralife by 21.3% in the third quarter. Barclays PLC now owns 13,395 shares of the technology company’s stock valued at $121,000 after purchasing an additional 2,355 shares during the last quarter. Juncture Wealth Strategies LLC bought a new position in Ultralife in the third quarter worth about $165,000. Jane Street Group LLC purchased a new stake in shares of Ultralife during the third quarter valued at about $166,000. Finally, XTX Topco Ltd boosted its holdings in shares of Ultralife by 192.1% in the 2nd quarter. XTX Topco Ltd now owns 37,399 shares of the technology company’s stock valued at $397,000 after buying an additional 24,595 shares in the last quarter. Institutional investors own 30.68% of the company’s stock.
Ultralife Company Profile
Ultralife Corporation, together with its subsidiaries, designs, manufactures, installs, and maintains power, and communication and electronics systems worldwide. The company operates in two segments, Battery & Energy Products and Communications Systems. The Battery & Energy Products segment offers lithium 9-volt, cylindrical, thin lithium manganese dioxide, rechargeable, and other non-rechargeable batteries; lithium-ion cells, multi-kilowatt module lithium-ion battery systems, and uninterruptable power supplies; and rugged military and commercial battery charging systems and accessories, including smart chargers, multi-bay charging systems, and various cables.
Further Reading
- Five stocks we like better than Ultralife
- What is the S&P/TSX Index?
- 3 Must-Hold Stocks with Double-Digit Upside for 2025
- How to Use Stock Screeners to Find Stocks
- Micron: Why Now Is the Time to Be Brave
- 3 Stocks to Consider Buying in October
- 3 Stocks That Wall Street Insiders Can’t Stop Buying
Receive News & Ratings for Ultralife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ultralife and related companies with MarketBeat.com's FREE daily email newsletter.